Trial Profile
Bupropion for hot flashes control in breast cancer survivors: A prospective, double-blind, randomized cross-over pilot phase II trial.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Jun 2011
Price :
$35
*
At a glance
- Drugs Bupropion (Primary)
- Indications Depressive disorders; Hot flashes
- Focus Therapeutic Use
- 30 Jun 2011 New trial record
- 07 Jun 2011 Results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.